Qube Research & Technologies (QRT)
FLNA

Qube Research & Technologies (QRT)’s Filana Therapeutics FLNA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-205
Closed -$4.62K – 4827
2023
Q4 		$4.62K Buy
+205
New +$4.33K ﹤0.01% 3724

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Qube Research & Technologies (QRT)'s FLNA Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of Filana Therapeutics (FLNA) in Q1 2024, closing a stake of 205 shares — an estimated $4.62K sold.

Qube Research & Technologies (QRT) first reported a position in FLNA in Q4 2023 and held it in 1 quarter. The position peaked at $4.62K in Q4 2023. 143 funds tracked by Wall St. Rank hold FLNA as of Q1 2024.

  • Qube Research & Technologies (QRT) reported no remaining Filana Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 205 Filana Therapeutics shares in Q1 2024, an estimated $4.62K.
  • Qube Research & Technologies (QRT) first reported a position in Filana Therapeutics in Q4 2023 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Filana Therapeutics position peaked at $4.62K in Q4 2023.
  • 143 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.